{"nctId":"NCT00086515","briefTitle":"Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-020)(COMPLETED)","startDateStruct":{"date":"2004-06-30","type":"ACTUAL"},"conditions":["Diabetes Mellitus, Type II"],"count":701,"armGroups":[{"label":"Sitagliptin 100 mg","type":"EXPERIMENTAL","interventionNames":["Drug: Sitagliptin (MK0431)","Drug: Metformin","Drug: Pioglitazone"]},{"label":"Placebo / Glipizide 5 mg","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo/Glipizide 5 mg","Drug: Metformin","Drug: Pioglitazone"]}],"interventions":[{"name":"Sitagliptin (MK0431)","otherNames":["MK0431","sitagliptin phosphate","Januvia"]},{"name":"Placebo/Glipizide 5 mg","otherNames":[]},{"name":"Metformin","otherNames":[]},{"name":"Pioglitazone","otherNames":["ACTOS"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patients with type 2 diabetes mellitus","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"78 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change From Baseline in Hemoglobin A1C (A1C) at Week 24","description":"A1C is measured as a percent. Thus, this change from\n\nbaseline reflects the Week 24 A1C percent minus the Week 0 A1C percent.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.67","spread":null},{"groupId":"OG001","value":"-0.02","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Fasting Plasma Glucose (FPG) at Week 24","description":"Change from baseline at Week 24 is defined as FPG at\n\nWeek 24 minus FPG at Week 0.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-16.9","spread":null},{"groupId":"OG001","value":"8.5","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in 2-hour Post-meal Glucose (PMG) at Week 24","description":"Change from baseline at Week 24 is defined as PMG at Week 24 minus PMG at Week 0.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-62.0","spread":null},{"groupId":"OG001","value":"-11.4","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":54,"n":464},"commonTop":["Upper Respiratory Tract Infection","Hypoglycaemia","Influenza","Nasopharyngitis","Back Pain"]}}}